#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15244	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2191	689.9	0	.	n	.	0	C451T	SNP	451	451	C	696	696	T	866	T,C	659,160	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15244	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2191	689.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1429	1429	C	924	C,A	864,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15244	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2191	689.9	0	HET	.	.	.	C1450T	.	1450	1450	C	1695	1695	C	840	C,T	617,161	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27374	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3535	770.6	0	.	n	.	0	T695C	SNP	695	695	T	966	966	C	814	C,T	578,182	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27374	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3535	770.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2242	2242	C	874	C,T	813,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27374	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3535	770.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2316	2316	A	864	A,T	815,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27374	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3535	770.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2868	2868	C	800	C,T	759,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27374	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3535	770.6	0	HET	.	.	.	G1337A	.	1337	1337	G	1608	1608	G	956	G,A	667,228	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2194	folP	855	855	100.0	folP.l6.c4.ctg.1	1575	138.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1065	1067	AGC	224;229;229	A;G;C	216;219;217	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5688	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3440	164.8	1	SNP	p	S91F	1	.	.	271	273	TTC	528	530	TTC	228;225;228	T;T;C	217;215;218	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5688	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3440	164.8	1	SNP	p	D95G	1	.	.	283	285	GGC	540	542	GGC	216;217;217	G;G;C	202;203;200	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5688	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3440	164.8	1	SNP	p	G95N	0	.	.	283	285	GGC	540	542	GGC	216;217;217	G;G;C	202;203;200	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1844	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1198	151.7	1	SNP	p	G45D	0	.	.	133	135	GGC	455	457	GGC	228;227;231	G;G;C	213;207;213	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	908	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1058	85.7	0	.	n	.	0	A197.	DEL	197	197	A	593	593	A	218	A	207	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2918	187.0	1	SNP	p	D86N	0	.	.	256	258	GAC	584	586	GAC	212;213;215	G;A;C	200;198;202	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2918	187.0	1	SNP	p	R87I	0	.	.	259	261	CGT	587	589	CGT	213;213;214	C;G;T	203;200;201	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2918	187.0	1	SNP	p	S87R	1	.	.	259	261	CGT	587	589	CGT	213;213;214	C;G;T	203;200;201	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2918	187.0	1	SNP	p	R87W	0	.	.	259	261	CGT	587	589	CGT	213;213;214	C;G;T	203;200;201	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2918	187.0	1	SNP	p	S88P	0	.	.	262	264	TCC	590	592	TCC	209;207;208	T;C;C	197;196;197	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4622	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2693	170.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1600	1602	GGC	222;222;220	G;G;C,A	204;202;195,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4326	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2451	175.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1339	1341	GCC	232;236;239	G;C;C,A	221;223;228,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4326	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2451	175.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1342	1344	ATG	243;245;248	A;T;G,C	227;234;235,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4326	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2451	175.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1354	1356	ACC	248;248;249	A,G;C,T;C,G	231,1;236,1;236,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4326	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2451	175.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1354	1356	ACC	248;248;249	A,G;C,T;C,G	231,1;236,1;236,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4326	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2451	175.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1855	1857	ACC	214;220;220	A;C;C	196;208;207	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4326	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2451	175.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1909	1911	GCG	220;215;215	G;C;G,A	208;208;207,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4326	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2451	175.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1909	1911	GCG	220;215;215	G;C;G,A	208;208;207,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4326	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2451	175.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2032	2034	GGT	168;166;167	G;G;T	162;163;159	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4326	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2451	175.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2041	2043	AGC	165;165;166	A;G;C	159;159;159	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4326	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2451	175.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2059	2061	CCG	161;161;160	C,G;C,G;G	125,4;130,2;128	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6110	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3194	190.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1622	1624	CCG	202;203;202	C;C;G	175;185;176	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2604	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1739	147.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	522	522	C	181	C	168	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3062	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1673	181.5	1	SNP	p	G120K	1	.	.	358	360	AAG	655	657	AAG	235;237;240	A;A;G	222;226;226	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3062	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1673	181.5	1	SNP	p	A121N	1	.	.	361	363	AAC	658	660	AAC	238;238;237	A;A;C	222;222;221	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3062	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1673	181.5	1	SNP	p	N121D	0	.	.	361	363	AAC	658	660	AAC	238;238;237	A;A;C	222;222;221	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10844	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4941	218.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1280	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1223	104.3	1	SNP	p	V57M	1	.	.	169	171	ATG	597	599	ATG	251;251;246	A;T;G	242;238;235	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
